1-5 of 5
Nancy Brandenburg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Over-The-Counter Aspirin Use In Patients Diagnosed With Multiple Myeloma

Susan A Oliveria, ScD, MPH, FISPE, Nancy Brandenburg, PhD, MPH, Syd Phillips, MPH, Kimberley J Woodcroft, PhD, MPH, Karen Wells, MPH, Marianne Ulcickas Yood, DSc, MPH, FISPE
Journal: Blood
Blood (2013) 122 (21): 1961.
https://doi.org/10.1182/blood.V122.21.1961.1961
Published: 2013
Journal Articles

Second Malignancies After Autologous Hematopoietic Cell Transplantation (AHCT) for Multiple Myeloma (MM): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis

Girindra Raval, Anuj Mahindra, MD, Xiaobo Zhong, MS, Ruta Brazauskas, PhD, Robert Peter Gale, MD, PhD, DSc, FACP, Nancy Brandenburg, PhD, Sagar Lonial, MD, Amrita Krishnan, MD, Angela Dispenzieri, MD, Parameswaran Hari, MBBS, MD, MRCP
Journal: Blood
Blood (2012) 120 (21): 591.
https://doi.org/10.1182/blood.V120.21.591.591
Published: 2012
Journal Articles

A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide

Brief Report
Meletios A. Dimopoulos, Paul G. Richardson, Nancy Brandenburg, Zhinuan Yu, Donna M. Weber, Ruben Niesvizky, Gareth J. Morgan
Journal: Blood
Blood (2012) 119 (12): 2764–2767.
https://doi.org/10.1182/blood-2011-08-373514
Published: 2012
Journal Articles

Lenalidomide Treatment Is Not Related to AML Progression Risk but Is Associated with a Survival Benefit in RBC Transfusion-Dependent Patients with IPSS Low- or Int-1-Risk MDS with del5q: Results From a Comparative Study

Andrea Kuendgen, MD, Michael Lauseker, Alan F. List, MD, Pierre Fenaux, MD, PhD, Aristoteles Giagounidis, MD, Nancy Brandenburg, PhD, Jay Backstrom, MD, Axel Glasmacher, MD, Joerg Hasford, MD, Ulrich Germing, MD, On behalf of the International Working Group on MDS with del5q
Journal: Blood
Blood (2011) 118 (21): 119.
https://doi.org/10.1182/blood.V118.21.119.119
Published: 2011
Journal Articles

Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes

Aristoteles Giagounidis, MD, Azra Raza, MD, Alan F. List, MD, Pierre Fenaux, MD, PhD, Bouchra Benettaib, MD, Benton Brown, MD, Jim Zhong, PhD, Nancy Brandenburg, PhD, Ghulam J. Mufti, MD
Journal: Blood
Blood (2011) 118 (21): 1704.
https://doi.org/10.1182/blood.V118.21.1704.1704
Published: 2011